Exploring iDose® TR: The Future of Glaucoma Management thumbnail

Exploring iDose® TR: The Future of Glaucoma Management

Published Nov 24, 24
1 min read


iDose® TR represents a revolutionary advancement in the treatment of glaucoma, offering a consistent and reliable option for managing intraocular pressure (IOP). Differing from traditional eye drops that need to be applied every day, iDose® TR is a small, implantable device crafted to provide a controlled medication delivery directly into the eye over an prolonged period. This groundbreaking approach eliminates the need for frequent dosing, significantly improving patient adherence and overall treatment results.

At Eye Center South, we are proud to offer iDose® TR as part of our all-encompassing glaucoma care. The device is implanted during a simple and low-risk procedure, ensuring patient comfort and convenience. Once in place, it delivers a steady release of glaucoma medication, keeping IOP levels consistent and ensuring your visual health. Patients who have difficulty managing the routine of applying eye drops daily can find relief from this next-generation treatment.



Visit for more info At Eye Center South